Explore our range of syndicated reports, datasets, and educational resources designed to equip you with actionable insights and strategic guidance. Whether you're navigating oncology trends or enhancing your team's expertise, we offer tailored solutions to support your success.
Syndicated Reports

Community Oncology Annual Trend Report
The 2024 Community Oncology Trend Report offers in-depth analysis on the following areas.
Enhanced Capabilities
Explore how community oncology clinics are investing in diagnostics, radiation oncology, administrative resources, and staffing to stay competitive.
Strategic Diversification
Learn how practices are diversifying referral sources and collaborating with other providers to address the rising competition from larger institutions.
Effective Engagement
Discover tailored strategies to engage with knowledgeable manufacturer representatives and support clinics in optimizing care.
By leveraging these insights, you can refine your approach to community oncology, optimize product positioning, and build stronger partnerships with these vital care providers.
Read more Show less
The 2024 Community Oncology Trend Report offers in-depth analysis on the following areas.
Enhanced Capabilities
Explore how community oncology clinics are investing in diagnostics, radiation oncology, administrative resources, and staffing to stay competitive.
Strategic Diversification
Learn how practices are diversifying referral sources and collaborating with other providers to address the rising competition from larger institutions.
Effective Engagement
Discover tailored strategies to engage with knowledgeable manufacturer representatives and support clinics in optimizing care.
By leveraging these insights, you can refine your approach to community oncology, optimize product positioning, and build stronger partnerships with these vital care providers.

IDN Annual Oncology Trend Report
The 2024 IDN Oncology Annual Trend Report is your comprehensive guide to navigating the evolving oncology landscape. Covering 147 IDNs across all U.S. regions, this report offers exclusive insights into:
- Growing Oncology Reach: Explore the rise in patient volumes and referrals across IDNs and their impact on oncology care.
- Sophisticated Drug Management: Understand the tools IDNs use—like formularies and high-cost drug reviews—and how they affect patient access.
- Effective Engagement: Gain actionable strategies from our new playbook to engage oncologists and pharmacists within IDNs.
With these insights, you can effectively position your products, align with IDN priorities, and enhance your engagement strategies.
Read more Show less
The 2024 IDN Oncology Annual Trend Report is your comprehensive guide to navigating the evolving oncology landscape. Covering 147 IDNs across all U.S. regions, this report offers exclusive insights into:
- Growing Oncology Reach: Explore the rise in patient volumes and referrals across IDNs and their impact on oncology care.
- Sophisticated Drug Management: Understand the tools IDNs use—like formularies and high-cost drug reviews—and how they affect patient access.
- Effective Engagement: Gain actionable strategies from our new playbook to engage oncologists and pharmacists within IDNs.
With these insights, you can effectively position your products, align with IDN priorities, and enhance your engagement strategies.

Landscape Report part 1
Part One: Key Market Trends & Strategies
Growing Oncology Reach
Explore the rise in patient volumes and referrals across IDNs and their impact on oncology care.
Sophisticated Drug Management
Understand the tools IDNs use—like formularies and high-cost drug reviews—and how they affect patient access.
Effective Engagement
Gain actionable strategies from our new playbook to engage oncologists and pharmacists within IDNs.
Read more Show less
Part One: Key Market Trends & Strategies
Growing Oncology Reach
Explore the rise in patient volumes and referrals across IDNs and their impact on oncology care.
Sophisticated Drug Management
Understand the tools IDNs use—like formularies and high-cost drug reviews—and how they affect patient access.
Effective Engagement
Gain actionable strategies from our new playbook to engage oncologists and pharmacists within IDNs.

Landscape Report part 2
Part Two: Navigating the Inflation Reduction Act (IRA)
Growing Oncology Reach
Explore the rise in patient volumes and referrals across IDNs and their impact on oncology care.
Sophisticated Drug Management
Understand the tools IDNs use—like formularies and high-cost drug reviews—and how they affect patient access.
Effective Engagement
Gain actionable strategies from our new playbook to engage oncologists and pharmacists within IDNs.
With these insights, you can effectively position your products, align with IDN priorities, and enhance your engagement strategies.
Read more Show less
Part Two: Navigating the Inflation Reduction Act (IRA)
Growing Oncology Reach
Explore the rise in patient volumes and referrals across IDNs and their impact on oncology care.
Sophisticated Drug Management
Understand the tools IDNs use—like formularies and high-cost drug reviews—and how they affect patient access.
Effective Engagement
Gain actionable strategies from our new playbook to engage oncologists and pharmacists within IDNs.
With these insights, you can effectively position your products, align with IDN priorities, and enhance your engagement strategies.
IDN Dataset / Analytics

Integrated Delivery Networks
As 2025 gets underway, reconnecting with key accounts is top of mind for many. For oncology drug manufacturers, having the right tools to navigate these conversations is critical. That’s where our Integrated Delivery Network (IDN) Dataset comes in, providing the insights and clarity you need to drive meaningful engagement with 147 unique IDNs.
What Makes the IDN Dataset Stand Out? The dataset includes comprehensive demographic and process data tailored to help you better understand and connect with IDNs, including:
- 52 NCI cancer centers
- 29 NCCN members
- 96 Acamademic health systems
This online dashboard enables you to anticipate and address the needs of IDN stakeholders effectively.
Read more Show less
As 2025 gets underway, reconnecting with key accounts is top of mind for many. For oncology drug manufacturers, having the right tools to navigate these conversations is critical. That’s where our Integrated Delivery Network (IDN) Dataset comes in, providing the insights and clarity you need to drive meaningful engagement with 147 unique IDNs.
What Makes the IDN Dataset Stand Out? The dataset includes comprehensive demographic and process data tailored to help you better understand and connect with IDNs, including:
- 52 NCI cancer centers
- 29 NCCN members
- 96 Acamademic health systems
This online dashboard enables you to anticipate and address the needs of IDN stakeholders effectively.
Training & Education

Clinical Pathways University
Clinical Pathways University is your gateway to success in a rapidly evolving healthcare landscape. Our comprehensive curriculum is designed to equip all levels of learners with the knowledge and skills necessary to thrive in a value-based care environment in which clinical pathways are a key component to driving precision and optimization of patient care. With our comprehensive courses, you’ll gain a deeper understanding of how clinical pathways are being used by payers and cancer care providers to address increasing healthcare costs, reduce variations in care, and support clinicians in staying on top of the latest advances in treatment.
Gain a deeper understanding of how clinical pathways can:
- Address rising healthcare costs
- Reduce variability
- Address rising healthcare costs
- Achieve better, more predictable clinical outcomes
- Drive success in a value-based care environment
We have five courses to choose from, or get a discount and purchase all courses as one package. Explore courses and packages.
Read more Show less
Clinical Pathways University is your gateway to success in a rapidly evolving healthcare landscape. Our comprehensive curriculum is designed to equip all levels of learners with the knowledge and skills necessary to thrive in a value-based care environment in which clinical pathways are a key component to driving precision and optimization of patient care. With our comprehensive courses, you’ll gain a deeper understanding of how clinical pathways are being used by payers and cancer care providers to address increasing healthcare costs, reduce variations in care, and support clinicians in staying on top of the latest advances in treatment.
Gain a deeper understanding of how clinical pathways can:
- Address rising healthcare costs
- Reduce variability
- Address rising healthcare costs
- Achieve better, more predictable clinical outcomes
- Drive success in a value-based care environment
We have five courses to choose from, or get a discount and purchase all courses as one package. Explore courses and packages.
IDN Essentials

Integrated Delivery Networks
IDN Essentials is your gateway to success in a rapidly evolving healthcare landscape. Our comprehensive curriculum is designed to equip all levels of learners with the knowledge and skills necessary to thrive in a value-based care environment in which integrated delivery networks (IDNs) are a key component to achieving a coordinated and seamless patient experience within a single collaborative system.
What You'll Learn:
- An understanding of the IDN landscape
- How IDNs drive value via incentives and other strategies
- IDNs’ impact on treatment decisions
- How to avoid pitfalls when partnering with external entities
- Who’s who among IDN stakeholders—and which personnel matter most
- How pharma and device manufacturers can become valued partners with IDNs
Register or sign in today to better understand how IDNs help simplify healthcare delivery, standardize systems and processes, and improve efficiency and effectiveness.
Read more Show less
IDN Essentials is your gateway to success in a rapidly evolving healthcare landscape. Our comprehensive curriculum is designed to equip all levels of learners with the knowledge and skills necessary to thrive in a value-based care environment in which integrated delivery networks (IDNs) are a key component to achieving a coordinated and seamless patient experience within a single collaborative system.
What You'll Learn:
- An understanding of the IDN landscape
- How IDNs drive value via incentives and other strategies
- IDNs’ impact on treatment decisions
- How to avoid pitfalls when partnering with external entities
- Who’s who among IDN stakeholders—and which personnel matter most
- How pharma and device manufacturers can become valued partners with IDNs
Register or sign in today to better understand how IDNs help simplify healthcare delivery, standardize systems and processes, and improve efficiency and effectiveness.
Research Opportunities

Research Opportunities
Join an elite group of oncology experts—including pharmacists, physicians, and payer executives—who contribute to critical research through focus groups, one-on-one interviews, and surveys. By participating, you’ll receive generous honoraria (not subject to sunshine reporting), access to the research reports you contribute to, and opportunities to network with peers.
Participant Compensation, Confidentiality, and Added Value
Our participants’ experience, insights, and time are extremely valuable, and we make sure they are compensated accordingly. Therefore, in return for participating, we offer our respondents several benefits:
- Generous honoraria (not subject to sunshine reporting)
- Copies of the research reports they contribute to
- Opportunities to meet and discuss important topics with peers and other industry experts
- Participant names are never included in our reports or shared with sponsors or other outside entities.
Research Recipients and Sponsors
Our syndicated double-blind research is sponsored primarily by more than 20 life science companies that use the information to better understand their customers. We are always excited to discuss specific topics and needs with participant organizations. If something is directly or indirectly important to you, it’s important to us too!
Let us know what you would like to learn more about.
Read more Show less
Join an elite group of oncology experts—including pharmacists, physicians, and payer executives—who contribute to critical research through focus groups, one-on-one interviews, and surveys. By participating, you’ll receive generous honoraria (not subject to sunshine reporting), access to the research reports you contribute to, and opportunities to network with peers.
Participant Compensation, Confidentiality, and Added Value
Our participants’ experience, insights, and time are extremely valuable, and we make sure they are compensated accordingly. Therefore, in return for participating, we offer our respondents several benefits:
- Generous honoraria (not subject to sunshine reporting)
- Copies of the research reports they contribute to
- Opportunities to meet and discuss important topics with peers and other industry experts
- Participant names are never included in our reports or shared with sponsors or other outside entities.
Research Recipients and Sponsors
Our syndicated double-blind research is sponsored primarily by more than 20 life science companies that use the information to better understand their customers. We are always excited to discuss specific topics and needs with participant organizations. If something is directly or indirectly important to you, it’s important to us too!
Let us know what you would like to learn more about.